If you have been suffering from baby archer symptoms, you are in luck.
If you are not already suffering from colic, you can now get a colic vaccine from the US, UK and Australia.
The first two countries have all announced their plans to provide the vaccine to their citizens.
However, the US has only announced that they will begin to provide a trial for its citizens starting on May 5th, while the UK and Australian governments are still working out the details.
You can see a list of countries offering colic vaccines here.
The Colic Vaccine, which is being offered in the US as part of the National Colic Program, is designed to be administered through the mouth or nose to children with a history of colic.
The vaccine will be administered at least two weeks before a parent or guardian is due to see a doctor.
The aim is to prevent the child from developing the symptoms of the condition, but this can be tricky to achieve.
According to the US Centers for Disease Control and Prevention, there are about 100,000 people in the United States who have been diagnosed with colic in their lifetime.
The number is expected to double by 2020, but experts believe that there could be as many as 150,000 cases per year, and that most of these cases are in children.
According in the UK, more than 30,000 adults have been treated for colic within the past decade.
While the number of children who have colic is still low, experts say the problem is becoming more common in the community, and it’s likely to be the case for the foreseeable future.
The US has also announced plans to launch its own Colic vaccine in 2018.
As with the Australian program, it is planned to be distributed to the population via a pilot program.
According the Centers for Diseases Control and Disease Control, the vaccine is intended to treat colic as a non-serious medical condition.
But, experts warn that it will still be important for those with the condition to get vaccinated.
You may also want to check out the UK’s Colic Report for more information on the matter.
This article originally appeared on TechRadars website.